Wang Li

发表

Structures and recognition modes of toll‐like receptors

Dong Gao, Wang Li, D. Gao, 2017, Proteins.

Novel TLR7 agonist stimulates activity of CIK/NK immunological effector cells to enhance antitumor cytotoxicity.

Dong Gao, Wang Li, Yongguang Cai, 2018, Oncology letters.

Antitumor activity of a novel small molecule TLR7 agonist via immune response induction and tumor microenvironment modulation.

Xinping Huang, Xiaodong Wang, L. Fu, 2016, Oncology reports.

Conjugation of weak ligands with weak antigens to activate TLR-7: A step toward better vaccine adjuvants.

Juan Zeng, Xiaodong Wang, Wenqi Jiang, 2016, European journal of medicinal chemistry.

Synthesis and immunoregulatory activities of conjugates of a Toll-like receptor 7 inert ligand.

F. Zhong, Xiaodong Wang, Wenqi Jiang, 2014, Bioorganic & medicinal chemistry letters.

Immunomodulatory and Antitumor Effects of a Novel TLR7 Agonist Combined with Lapatinib

Wenqi Jiang, Xiaodong Wang, Zhulin Wang, 2016, Scientific Reports.

Synergy of purine-scaffold TLR7 agonist with doxorubicin on systemic inhibition of lymphoma in mouse model

Wang Li, Yongguang Cai, Chih-Chang Wei, 2017, Journal of Cancer.

Local administration of a novel Toll-like receptor 7 agonist in combination with doxorubicin induces durable tumouricidal effects in a murine model of T cell lymphoma

D. Zheng, Wenqi Jiang, Shiping He, 2015, Journal of Hematology & Oncology.

Toll‐Like Receptor 7 Inactive Ligands Enhanced Cytokine Induction by Conjugation to Weak Antigens

Wenqi Jiang, Zhulin Wang, Guangyi Jin, 2015, ChemMedChem.

Conjugation of toll-like receptor-7 agonist to gastric cancer antigen MG7-Ag exerts antitumor effects.

Xiao-dong Wang, Ningning Gao, Wang Li, 2015, World journal of gastroenterology.